Display search results for ** instead (309 products)
02 Oct 2020  |  Global
Biosimilar Access to Newer Therapy Areas such as Ophthalmology to drive major growth of Biosimilar Market, 2020-2026
Outsourced manufacturing of complex third wave of biosimilars to spark new growth opportunities
The Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry highlighting the key growth opportunities, market revenue forecast and trends that will influence the industry with the third wave biosimilars. The global third wave biosimilars market covered in this study includes 2 major segments â...
USD 4,455.00 save 10 %
28 Aug 2020  |  Global
Part I: Drug Discovery Applications
Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...
21 Aug 2020  |  Global
Patient-centric and Safety-focused Logistical Solutions will Create New Growth Opportunities
In this research deliverable, Frost & Sullivanâ€™s analyst team offers a bold perspective on the post-pandemic growth opportunities for the global CRO market. With the increased threat of COVID-19 and world-wide lockdowns in effect, the contract research organization (CROs) market is seeing interruptions in ongoing clinical trials and delays of new...
03 Aug 2020  |  Global
Genetic tools for next-generation animal models for preclinical research
This study provides insights across recent advances across the use of animal disease models in preclinical research.It encompasses the following aspects: Technology roadmap, market trends, capabilities, and targeted application Stakeholder activities, influence, industry initiatives Investment environment and funding support Industry evolution and ...
24 Jul 2020  |  North America
Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies
With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments â€“ antibody therapies,...
09 Jul 2020  |  North America
Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of â€˜Healthcare Preparednessâ€™
Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-1...
07 Jul 2020  |  Global
Emerging Chimeric Antigen Receptor (CAR) T-cell Therapy Platforms
This research identifies some the key developments across CAR-T cell therapies and provides insights across technological, IP, and investment landscapes. The study also provides an analysis of the competitive landscape while highlighting the key growth opportunities within the CAR-T cell therapy platform.
29 Jun 2020  |  Global
Leveraging Growth Opportunities in Emerging Economies Spurred by Affordable and Accessible Medical Device Innovations
According to the World Health Organization, at least half of the worldâ€™s population do not have access to essential health services due to the high healthcare costs. Frugal medical device innovations can improve the healthcare accessibility and quality of care to the people, especially those at lower socio-economic status. This research service (...
29 Jun 2020  |  Global
Growing Viral Vector Contract Development Manufacturing Landscape
The rise in gene therapies over the last few years has created a huge opportunity for viral vector Contract Research Development Organization (CMO/CDMO) to fill the gap of high demand and shortage of viral vectors. As of January 2020, the US Food and Drug Administration FDA has approved four gene therapies and claims to have over 900 therapies i...
24 Jun 2020  |  Global
Bioengineering Innovations in Preclinical Research
The key focus of this research has been outlined as below: 1. Technology benchmarking and roadmap, market trends, capabilities, and applications targeted: Build a robust strategy by defining the universe of preclinical disease models opportunities and setting key priorities 2. Stakeholder activities, influence, industry initiatives: Evaluate opport...